Evidence based administration of risperidone and paliperidone for the treating conduct disorder
- PMID: 24523788
- PMCID: PMC3906794
Evidence based administration of risperidone and paliperidone for the treating conduct disorder
Abstract
Background: This study evaluates the evidence-based administration of risperidone and paliperidone for the treating children and adolescents with conduct disorder (CD).
Materials and methods: A review of the current literature from clinical trials that investigated the efficacy of risperidone and paliperidone on CD considering the inclusion criteria and search strategies was performed by a search of PubMed and Google Scholar databases.
Results: Out of 53 titles, 31 were irrelevant. The abstract of 22 potentially related articles were studied. Only six articles reported the results of clinical trial. However, one of them reported the effect of risperidone on conduct behaviors in autistic disorders. One study was a re-analysis of two previous studies, one study reported the effects of maintenance versus withdrawal of risperidone treatment and two studies included children with sub-average intelligence. Headache, somnolence and increased appetite are among the most common reported adverse effects. No study examined the effect of paliperidone on CD was found.
Conclusion: Current literature suggests that risperidone could be effective for treating some conduct behaviors in children and adolescents. The effect of risperidone on CD is not a well-researched area. There is no well-controlled evidence based reports about the safety and efficacy of risperidone for the treatment of CD. Further trials should examine the efficacy of these medications on CD rather than conduct behaviors or disruptive behavior disorders.
Keywords: Conduct disorder; paliperidone therapeutic; risperidone.
Conflict of interest statement
Figures
Similar articles
-
Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.Pediatrics. 2002 Sep;110(3):e34. doi: 10.1542/peds.110.3.e34. Pediatrics. 2002. PMID: 12205284 Clinical Trial.
-
Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.J Child Adolesc Psychopharmacol. 2004 Summer;14(2):243-54. doi: 10.1089/1044546041649020. J Child Adolesc Psychopharmacol. 2004. PMID: 15319021 Clinical Trial.
-
Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1026-36. doi: 10.1097/00004583-200209000-00002. J Am Acad Child Adolesc Psychiatry. 2002. PMID: 12218423 Clinical Trial.
-
Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.Clin Ther. 2008 Feb;30(2):231-48. doi: 10.1016/j.clinthera.2008.02.011. Clin Ther. 2008. PMID: 18343262 Review.
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
References
-
- 4th ed. Washington, DC: American Psychiatric Association; 2000. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR.
-
- Colins O, Vermeiren R, Vreugdenhil C, van den Brink W, Doreleijers T, Broekaert E. Psychiatric disorders in detained male adolescents: A systematic literature review. Can J Psychiatry. 2010;55:255–63. - PubMed
-
- Ghanizadeh A, Nouri SZ, Nabi SS. Psychiatric problems and suicidal behaviour in incarcerated adolescents in the Islamic republic of Iran. East Mediterr Health J. 2012;18:311–7. - PubMed
-
- Ghanizadeh A, Mohammadi MR, Moini R. Comorbidity of psychiatric disorders and parental psychiatric disorders in a sample of Iranian children with ADHD. J Atten Disord. 2008;12:149–55. - PubMed
Publication types
LinkOut - more resources
Full Text Sources